GW Pharmaceuticals' Epidiolex – the first drug derived from marijuana to receive...

...FDA approval – is now available nationwide. So far, the therapy currently appears on the preferred tier for 7% of covered lives, and is not covered for 51% of all insured lives. The drug treats two rare forms of childhood epilepsy, Lennox-Gastaut syndrome and Dravet syndrome.